Chonluten is a tripeptide bioregulator originally developed as part of peptide research focused on tissue-specific cellular regulation. The peptide consists of the amino acid sequence Glutamic Acid–Aspartic Acid–Arginine (EDR) and has been studied for its potential role in supporting respiratory tissue function and cellular homeostasis.
Research suggests that Chonluten may influence gene expression associated with lung tissue maintenance, cellular repair mechanisms, and age-related biological changes. Due to these properties, it has become a subject of interest in studies involving respiratory health, longevity science, and regenerative medicine.
Chonluten is supplied as a lyophilized powder and is intended strictly for laboratory research and analytical applications. It is not approved for human consumption, medical treatment, or diagnostic use.



Reviews
There are no reviews yet.